Patent details

LUC00308 Product Name: Spesolimab, un anticorps anti-IL-36R

Basic Information

Publication number:
LUC00308
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP127884104
Legal Status:
Pending & Published
Application number:
LUC00308
First applicant's nationality:
Procedural language:
French

Paediatric Extension

SPC Extension Filing Date:
15/01/2025
SPC Extension Agent Name:
ARONOVA S.A.
SPC Extension Status:
Pending & Published
SPC Extension Grant Date:
SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/22/1688
Marketing Authorization Type:
Marketing Authorization Date:
12/12/2022
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
31/05/2023
First Marketing Authorization date:
12/12/2022
Grant date:
Activation date:
Publication date:
02/06/2023
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
14/11/2037
SPC Extension Expiration:
14/05/2038
Rejection date:
Withdrawal date:

Owner

From:
31/05/2023
 
 

Name:
Boehringer Ingelheim International GmbH
Address:
Binger Strasse 173, 55216 Ingelheim am Rhein, Germany (DE)

Agent

Name:
ARONOVA S.A.
From:
31/05/2023
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2023/08
Publication date:
03/07/2023
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPCX1
Bulletin edition number:
2025/02
Publication date:
06/02/2025
Description:
Section G : Applications for extensions for pediatric use – I1E publication

Annual Fees

Annual Fee Due Date:
30/11/2032
Annual Fee Number:
21
Annual Fee Amount:
410 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer: